Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions

PURPOSE: A fixed-dose combination (FDC) tablet of melitracen/flupentixol has been widely used for depression. The purpose of this study was to assess the safety profile and the relative bioavailability of two FDC products containing 10 mg melitracen and 0.5 mg flupentixol from two different manufact...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Autores principales: Wu, Lihua, Xu, Chang, Wu, Guolan, Zhou, Huili, Lv, Duo, Zhai, You, Huang, Yujie, Tang, Wenling, Li, Fangqiong, Shentu, Jianzhong
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756841/
https://ncbi.nlm.nih.gov/pubmed/31571834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S207561
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares